Browse the latest stories and reports on MSF from various media outlets.

Country/Region

June 28, 2013

A House subcommittee held a hearing on international trade disputes with India. Most of the event was devoted to U.S. drug company Pfizer's complaints about Indian policies that have fostered the country's billion-dollar generics industry.

June 25, 2013

South Africa has made major progress in the fight against AIDS since 2001, when MSF was the only organization providing antiretroviral treatment in the country. "Adherence clubs" piloted by MSF now make treatment more accessible than ever.

April 02, 2013

  A landmark ruling by India's Supreme Court underscores the need for patients to have access to generic medications at affordable prices, according to MSF's Jennifer Cohn.

August 21, 2012

Novartis AG goes to India's Supreme Court on Wednesday to seek patent protection for its blockbuster cancer drug Glivec in a case that could deliver far-reaching ramifications for multinational pharmaceutical companies operating in India.... Novartis's critics, including Médecins Sans Frontières [Doctors Without Borders], say that if the company prevails, it could set a legal precedent that allows pharmaceutical giants to patent a range of drugs in India that are now available from generic producers, including HIV medicines. That would demolish a thriving low-cost industry and lead to higher prices, not just in India, they say, but elsewhere in the developing world where India is a major exporter of drugs.

February 09, 2012

Hundreds of people marched in New Delhi on Friday to protest an ambitious free-trade agreement being negotiated between India and the European Union that patient groups and health activists say could severely curtail India's production and export of affordable drugs for millions living with HIV in developing countries.

November 07, 2011

A four-year test of drugs to treat a widespread parasitic disease called kala azar is announced by the governments of India and Bangladesh, Doctors Without Borders, the Drugs for Neglected Diseases Initiative and other groups

View external media 

January 19, 2011

Are the European Union and its multinational pharmaceutical companies now pressuring the Indian prime minister's office? In recent months, as negotiators from India and Europe have been thrashing out the details of a free trade agreement to be signed within months, people living with HIV have been hitting the streets. From New Delhi to Nairobi and Brussels to Bangkok, they have been protesting against the very real threat posed to India's ability to supply life-saving generic medicines to people across the developing world.  

November 29, 2010

The recent report on AIDS in South Africa, where Doctors Without Borders has been providing AIDS treatment for 10 years, lays out stark policy choices its government must make in order to reduce AIDS deaths and avert millions of infections in the next 20 years.

View external media

April 20, 2010

Not a week seems to go by without the West -- governments, pharmaceutical giants and the business press -- crying foul over India's handling of intellectual property. As a doctor, speaking from a medical humanitarian perspective, the case for a defense of India is clear: competition between multiple manufacturers allows for lower prices and greater access to lifesaving medicines.

December 09, 2009

Eric Goemaere hopes the patent pool will work out so he doesn't have to watch his patients in Khayelitsha die. In the U.S. HIV patients have a 69-year life expectancy. But his patients in Khayelitsha are running out of options after only 8 years on therapy. "I don't accept the principle of double standards," he says. "If it's possible to get 69 years of life in the U.S., it should be possible to get something comparable in South Africa."

Pages